Jump to content

Xellia

From Wikipedia, the free encyclopedia
Xellia ApS
Company typeAktieselskab
IndustryPharmaceuticals, health care[1]
Founded1958[1]
HeadquartersCopenhagen, Denmark[1]
Websitehttp://www.xellia.com

Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen[1] specialized in the production of anti-biotics, including Vancomycin[2] and Bacitracin.[3]

The company's US base of operations is in Buffalo Grove, Illinois,[4][5] with additional facilities in Ohio, and North Carolina.[6][7] In 2018, Xellia's sales in the United States accounted for 60% of its total revenue.[5]

Products

[edit]

The company's main output is bulk drug chemicals which are wholesaled to other companies for packaging and distribution. Recently some prepackaged goods have been produced.

Active drug substances manufactured are:[8]

ATC Substance Structural formula Formulation for sale Production started
D06AX05 (WHO) (FK)
J01XX10 (WHO) (FK)
R02AB04 (WHO) (FK)
QA07AA93 (WHO) (FK)
Bacitracin (MT)[9][10] Bacitracin 1952
D06AX05 (WHO) (FK)
J01XX10 (WHO) (FK)
R02AB04 (WHO) (FK)
QA07AA93 (WHO) (FK)
Bacitracin (MT)[9][10] Bacitracin zinc 1958
Colistimethate natrium (CMS)
A07AA10 (WHO) (FK)
J01XB01 (WHO) (FK)
QJ51XB01 (WHO) (FK)
Colistin Colistin sulfate 1969
J01X X09 Daptomycin (MT)[9][11] Daptomycin
R02AB30 (WHO) (FK) Gramicidin
A07AA05 (WHO) (FK)
J01XB02 (WHO) (FK)
S01AA18 (WHO) (FK)
S02AA11 (WHO) (FK)
S03AA03 (WHO) (FK)
QJ51XB02 (WHO) (FK)
Polymyxin B (MT)[9][12] Polymyxin B-sulfate 1968
J01GB01 (WHO) (FK)
S01AA12 (WHO) (FK)
Tobramycin (MT)[9][13] Tobramycin sulfate 2005
D06AX08 (WHO) (FK)
R02AB02 (WHO) (FK)
S01AA05 (WHO) (FK)
Tyrothricin Tyrothricin
A07AA09 (WHO) (FK)
J01XA01 (WHO) (FK)
Vancomycin (MT)[9][14] Vancomycin hydrochloride 2003
A01AB04 (WHO) (FK)
A07AA07 (WHO) (FK)
G01AA03 (WHO) (FK)
J02AA01 (WHO) (FK)
Amfotericin B (MT)[9][15] Amfotericin B 1985
J02AX04 (WHO) (FK) Caspofungin (MT)[9][16] Caspofungin acetate
D07AC17 (WHO) (FK)
R01AD08 (WHO) (FK)
R01AD58 (WHO) (FK)
R03BA05 (WHO) (FK)
Fluticasone (MT)[9][17] Fluticasone propionate
D07AC13 (WHO) (FK)
R01AD09 (WHO) (FK)
R03BA07 (WHO) (FK)
Mometasone (MT)[9][18] Mometasone furoate

Discontinued products

[edit]

Previously the company also produced:

Ingredient Produced
Neomycin 1952-?
Tetracycline 1961-?

Partnerships

[edit]

In 2019, Xellia partnered with Civica Rx to produce generic Vancomycin and Daptomycin. The partnership's stated aim is to remedy chronic drug shortages that have affected the American pharmaceutical market.[4][19][20][21][22]

China-US Trade War

[edit]

Xellia has been discussed as a potential alternative to Chinese companies for anti-biotic primary ingredients in the context of the China-United States trade war.[23]

See also

[edit]

References

[edit]
  1. ^ a b c d "Xellia Pharmaceuticals ApS". Bloomberg. 2019-05-15. Retrieved 15 July 2019.
  2. ^ "VANCOMYCIN HYDROCHLORIDE". U.S. National Library of Medicine. 2019-05-15. Retrieved 10 September 2019.
  3. ^ "BACITRACIN- bacitracin injection". U.S. National Library of Medicine. Retrieved 10 September 2019.
  4. ^ a b "Xellia to produce Civica antibiotics". Chicago Daily Herald. 2019-05-15. Retrieved 15 July 2019.
  5. ^ a b "Danish pharmaceutical company picks Chicago area for new office". Chicago Business Journal. Retrieved 15 July 2019.
  6. ^ "Will China Save the American Economy?". The Atlantic. 2017-06-27. Retrieved 15 July 2019.
  7. ^ "Denmark-based pharmaceuticals company acquires Raleigh manufacturing plant". Triangle Business Journal. Retrieved 21 July 2019.
  8. ^ produktet listen er hentet fra Api på xellia.com Archived 2015-08-27 at the Wayback Machine 15. august 2014 og supplert med informasjon fra Vår arv Archived 2015-08-24 at the Wayback Machine hentes samme dag
  9. ^ a b c d e f g h i j "Godkjent eller ikke godkjent – hvilke statuser kan et legemiddel ha?". Archived from the original on 28 August 2016. Retrieved 27 August 2016.
  10. ^ a b "Legemiddelsøk". Retrieved 27 August 2016.
  11. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  12. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  13. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  14. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  15. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  16. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  17. ^ "Legemiddelsøk". Retrieved 27 August 2016.
  18. ^ "Legemiddelsøk". Retrieved 4 September 2016.
  19. ^ "Two crucial antibiotics are the first products of Utah's new nonprofit drug company". Salt Lake Tribune. Retrieved 15 July 2019.
  20. ^ "Drugmaker Created To Reduce Shortages And Prices Unveils Its First Products". NPR. Retrieved 15 July 2019.
  21. ^ Evans, Melanie (15 May 2019). "Hospital Drug-Making Venture Picks Antibiotics as First Products". Wall Street Journal. Retrieved 15 July 2019.
  22. ^ Deam, Jenny (20 May 2019). "Unique initiative to lower drug prices signs manufacturer". Houston Chronicle. Retrieved 22 July 2019.
  23. ^ "Trade War With China Threatens To Make Problems With Generic Medicine Worse". Forbes. Retrieved 15 July 2019.